154 related articles for article (PubMed ID: 37439938)
1. MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.
Pons-Escoda A; Garcia-Ruiz A; Garcia-Hidalgo C; Gil-Solsona R; Naval-Baudin P; Martin-Noguerol T; Fernandez-Coello A; Flores-Casaperalta S; Fernandez-Viñas M; Gago-Ferrero P; Oleaga L; Perez-Lopez R; Majos C
Eur Radiol; 2023 Dec; 33(12):9120-9129. PubMed ID: 37439938
[TBL] [Abstract][Full Text] [Related]
2. Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis.
Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Grussu F; Fernandez JJS; Simo AC; Sarro NV; Fernandez-Coello A; Bruna J; Cos M; Perez-Lopez R; Majos C
Eur Radiol; 2022 Jun; 32(6):3705-3715. PubMed ID: 35103827
[TBL] [Abstract][Full Text] [Related]
3. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI.
Kurokawa R; Kurokawa M; Baba A; Kim J; Capizzano A; Bapuraj J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Nov; 101(44):e31708. PubMed ID: 36343086
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
6. Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentiles.
Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Martinez-Zalacain I; Castell J; Camins A; Vidal N; Bruna J; Cos M; Perez-Lopez R; Oleaga L; Warnert E; Smits M; Majos C
Eur Radiol; 2024 Jan; ():. PubMed ID: 38282078
[TBL] [Abstract][Full Text] [Related]
7. Histogram Analysis of Diffusion Tensor Imaging Parameters in Pediatric Cerebellar Tumors.
Wagner MW; Narayan AK; Bosemani T; Huisman TA; Poretti A
J Neuroimaging; 2016 May; 26(3):360-5. PubMed ID: 26331360
[TBL] [Abstract][Full Text] [Related]
8. Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI.
Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Cos M; Vidal N; Plans G; Bruna J; Perez-Lopez R; Majos C
AJNR Am J Neuroradiol; 2020 Oct; 41(10):1816-1824. PubMed ID: 32943424
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of Cerebellar Hemisphere Tumors: Combining Apparent Diffusion Coefficient Histogram Analysis and Structural MRI Features.
Payabvash S; Tihan T; Cha S
J Neuroimaging; 2018 Nov; 28(6):656-665. PubMed ID: 30066449
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion-Weighted Imaging, and Dynamic Susceptibility-Contrast Perfusion-Weighted Imaging Combined With Conventional Magnetic Resonance Imaging.
Li Y; Wang P; Zhang J; Li J; Chen L; Qiu X
J Magn Reson Imaging; 2022 Oct; 56(4):1232-1242. PubMed ID: 35278008
[TBL] [Abstract][Full Text] [Related]
11. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
13. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
[TBL] [Abstract][Full Text] [Related]
14. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
15. MR signal of the solid portion of pilocytic astrocytoma on T2-weighted images: is it useful for differentiation from medulloblastoma?
Arai K; Sato N; Aoki J; Yagi A; Taketomi-Takahashi A; Morita H; Koyama Y; Oba H; Ishiuchi S; Saito N; Endo K
Neuroradiology; 2006 Apr; 48(4):233-7. PubMed ID: 16550430
[TBL] [Abstract][Full Text] [Related]
16. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of pilocytic and pilomyxoid astrocytomas using dynamic susceptibility contrast perfusion and diffusion weighted imaging.
Ho CY; Supakul N; Patel PU; Seit V; Groswald M; Cardinal J; Lin C; Kralik SF
Neuroradiology; 2020 Jan; 62(1):81-88. PubMed ID: 31676961
[TBL] [Abstract][Full Text] [Related]
18. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Brain Tumour Perfusion Using Early-Phase
Filss CP; Cramer J; Löher S; Lohmann P; Stoffels G; Stegmayr C; Kocher M; Heinzel A; Galldiks N; Wittsack HJ; Sabel M; Neumaier B; Scheins J; Shah NJ; Meyer PT; Mottaghy FM; Langen KJ
Mol Imaging Biol; 2024 Feb; 26(1):36-44. PubMed ID: 37848641
[TBL] [Abstract][Full Text] [Related]
20. Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
Kurokawa R; Kurokawa M; Baba A; Kim J; Srinivasan A; Moritani T
PLoS One; 2023; 18(7):e0288412. PubMed ID: 37450487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]